Comparison of the Efficacy between Dexmedetomidine plus Morphine Patient-Controlled Analgesia (PCA) and Morphine Patient-Controlled Analgesia (PCA) Alone for Pain Control in Postoperative Valvular Heart Surgery

Main Article Content

Pathawat Plengpanich


Introduction: Postoperative pain after valvular heart
surgery is moderate to severe pain. Morphine was
generally used, but it has undesirable dose-related side
effects. Dexmedetomidine an analgesic adjuvant may
reduce morphine used.
Objectives: To compared the efficacy between
dexmedetomidine plus morphine patient-controlled
analgesia (PCA) and morphine PCA alone postoperatively.
Methods: This randomized controlled trial assigned
32 patients undergoing valvular heart disease into
2 groups included D group (dexmedetomidine; n=16)
received dexmedetomidine after extubation with loading
dose 1 mcg/kg then infused 0.3 mcg/kg/h and P group
(placebo; n= 16); combined with PCA morphine
postoperatively in both groups. Postoperative cumulative
morphine consumption at 24 and 48 h and pain scores at
time points of 0, 6, 12, 24 and 48 h were recorded.
Results: The cumulative morphine consumption was
not statistically significant in both groups within 48 h
postoperatively (D vs. P group = 16.94 ± 7.56 mg vs.
15.00 ± 6.46 mg, 95%CI -2.05-2.55, p-value = 0.826).
The D group had numeric rating scale (NRS) value at rest
lower than P group significantly at 12 h postoperative

(0.06 ± 0.25 and 0.88 ± 1.50, mean different = -0.81,
95%CI -1.59 to -0.04, p-value = 0.041) and 24 h
postoperative (0 and 0.44 ± 0.81, mean different = -0.44,
95%CI -0.85 to -0.02, p-value = 0.040). The NRS at rest
in the other time and on movement in any time did not
different between groups.
Conclusion: Dexmedetomidine 0.3 mcg/kg/h cannot
decrease cumulative morphine consumption within 48 h
postoperatively as an adjunct to morphine PCA.

Article Details

Original articles


1. Ghandi I, Alavi SM, Babaee T, et al. The analgesic effect of
morphine and dexmedetomidine intravenous patientcontrolled
analgesia method to control pain after open
cardiac surgery: A randomized control trial. Arch Crit Care
Med 2015;1(3):e6453. doi: 10.17795/accm-6453.
2. Abd Aziz N, Chue MC, Yong CY, et al. Efficacy and safety of
dexmedetomidine versus morphine in post-operative cardiac
surgery patients. Int J Clin Pharm. 2011;33:150-4.
3. Wang X, Liu W, Xu Z, et al. Effect of dexmedetomidine alone
for intravenous patient-controlled analgesia after gynecological
laparoscopic surgery. Medicine (Baltimore) 2016;95:1-7.
4. Kim SY, Chang CH, Lee JS, et al. Comparison of the efficacy
of dexmedetomidine plus fentanyl patient-controlled
analgesia with fentanyl patient-controlled analgesia for pain
control in uterine artery embolization for symptomatic fibroid
tumors or adenomyosis: A Prospective, Randomized Study.
J Vasc Interv Radiol 2013;24:779-86.
5. Highlights of prescribing information (dexmedetomidine
hydrochlo-ride) [Internet]. 2013 [cited 2018 Feb 19].
Available from:
6. Naik BI, Nemergut EC, Kazemi A, et al. The effect of
dexmedetomidine on postoperative opioid consumption and
pain after major spine surgery. Anesth Analg 2016;122:1646-53.
7. Tang C, Xia Z. Dexmedetomidine in perioperative acute pain
management: a non-opioid adjuvant analgesic. J Pain Res.
8. Gertler R, Brown HC, Mitchell DH, et al. Dexmedetomidine:
a novel sedative-analgesic agent. Proc Bayl Univ Med Cent.
9. Sadhasivam S, Boat A, Mahmoud M. Comparison of patientcontrolled
analgesia with and without dexmedetomidine
following spine surgery in children. J Clin Anesth 2009;21: